A Collaborative Webinar Series between The Transplantation Society, the Indian Society of Critical Care Medicine, the Indian Society of Transplantation, and the International Society for Organ Donation and Procurement.
Presentation 7 - Organ Donation and Transplantation: Coexisting with COVID-19
Thursday, March 17, 2022, 10:00 AM
(Local time in Montreal) Local time (Corresponding local time at your current location)
The duration of this presentation is scheduled for 60 minutes
Beatriz Domínguez-Gil is medical doctor, specialist in Nephrology. PhD in internal medicine. She joined the National Transplant Organization (ONT) in November 2006 and became its Director General in May 2017. ONT is the Spanish national authority responsible for the oversight, coordination and organization of the donation and clinical use of organs, tissues and cells.
Immediate past chair of the Committee of Transplantation of the Council of Europe (CD-P-TO), President of the Iberoamerican Network/Council on Donation and Transplantation (RCIDT), Member of the WHO Task Force to promote ethical practices in the donation and transplantation of organs, tissues and cells.
Past Co-Chair of the Declaration of Istanbul Custodian Group on Organ Trafficking and Transplant Tourism; Past President of the European Donor Transplant Coordination Organization (EDTCO), Past Chair of the Ethics Committee of The Transplantation Society (TTS), Past Councilor for Europe at the TTS.
She has more than 190 publications in scientific journals and book chapters. She has presented more than 320 communications and papers at national and international conferences.
Department of Critical Care Department of Anesthesia, Pain Management & Perioperative Medicine
Dalhousie University, Halifax, Canada
Dr. Stephen Beed is a clinician at heart and has completed postgraduate training focused on Adult Critical Care Medicine plus Thoracic and Cardiovascular Anesthesia. His current clinical focus is in the Intensive Care Unit. Dr. Beed has recently been awarded the position of President-Elect (2019-2021) for the International Society of Organ Donation and Procurement Council. Having served as the Medical Advisor for the Nova Scotia Organ and Tissue Donation Program since its inception in 2006, he continues to contribute to the development of optimal care for organ and tissue donation by also serving as the Clinical Lead for the new presumed-consent legislation that has passed in Nova Scotia. He has also served at the national level by having served as National Chair of the Deceased Donation Advisory Committee (2008-2018) as well as serving as a member of the Organ Donation and Transplantation Expert Advisory Committee through Canadian Blood Services.
The impact of COVID-19 on organ donation and transplantation in the world
Vivek Kute, MD, DM Nephrology(Gold Medal), FASN, FRCP(London), is a Professor and Unit Head Nephrology and Transplantation at Institute of Kidney Diseases and Research Center and Dr. H L Trivedi Institute of Transplantation Sciences (IKDRC-ITS), B J Medical College Ahmedabad, India. He is Secretary of the Indian Society of Organ Transplantation, member of the Scientific Program Committee for the TTS 2020 Seoul, Korea, congress, Councilor of The Transplantation Society (TTS), Councilor of Asian Society of Transplantation, member of the WHO Task Force Transplantation, member of the Declaration of Istanbul Custodian Group, member of Apex technical committee of National Organ and Tissue Transplant Organization,and ERAEDTA YNP Board of Advisors. IKDRC-ITS has completed 6100 kidney transplants including 925 deceased donor and 440 kidney exchanges. Dr. Kute’s vision for TTS includes outreach to developing countries and enhancing global alliances to Improve transplant registry outcome and access to transplantation, and to help promote TTS, its Mission and its Ethics in Asia and Globally. Dr. Kute has 150 peer-reviewed publications.
Evaluation and selection of potential organ donors with regards to COVID-19
Divisions of Infectious Diseases and Organ Transplantation
Dr. Michael Ison was born in St. Petersburg, Florida. He attended Grinnell College where we received his Bachelor of Arts in Chemistry and Chinese Studies before returning to Florida where he obtain is medical degree at the University of South Florida College of Medicine. He then completed his Internal Medicine Residency and General Internal Medicine Fellowship at Oregon Health Sciences University in Portland, Oregon. He then obtained his Master of Science in Health Evaluation Sciences and did his Infectious Diseases Fellowship at the University of Virginia. During his fellowship, he was mentored by Drs. Fredrick Hayden, Larisa Gubareva, and Tom Brachiale. His research focused on the immunopathogenesis of influenza and its treatment in immunosuppressed and hospitalized patients. He developed a immunocompromised mouse model of influenza to study the development of antiviral resistance. In addition, he did studies of the pharmacokinetics and outcomes of treatment with oseltamivir, zanamivir, and rimantidine in hospitalized patients. After leaving the University of Virginia, he undertook additional training in Transplant Infectious Diseases at the Massachusetts General Hospital and Harvard Medical School under the mentorship of Dr. Jay A. Fishman. He then joined the faculty of the Divisions of Infectious Diseases and Organ Transplantation at Northwestern University Feinberg School of Medicine in 2005. He is currently the Medical Director of the Transplant & Immunocompromised Host Infectious Diseases Service, Northwestern University Comprehensive Transplant Center.
He has continued to be a significant researcher in the field of transplant infections. His primary focus is on respiratory viruses in this unique population. He was a lead investigator for studies to determine how to prevent and treat influenza in immunocompromised patients. Additionally, he is considered an expert in adenovirus infections in immunosuppressed patients and has contributed to the design of several treatment studies for adenovirus. He has also participated in a number of studies to optimize the management of CMV, BK virus, Norovirus and fungal infections in transplant recipients. Dr. Ison has also been heavily involved in describing the epidemiology of donor-derived disease transmission among organ recipients.
Dr. Ison is currently the Past President of the Transplant Infectious Diseases Section of TTS.
A dynamic approach to the management of organ donation and transplantation programs in the COVID-19 era
Dr. Massimo Cardillo has been officially appointed by the Italian Minister of Health as Director General of the Italian National Transplant Centre from March 11th, 2019 for five years.
Dr. Cardillo graduated in medicine at Milan University. He got a specialty as haematologist and has been active in the organ donation and transplant field since 1992. Being involved in management and coordination of Nord Italia Transplant, the first interregional organization that was set up in Italy. Dr Cardillo is author of 84 scientific articles on national and international journals and responsible for 11 scientific projects.